Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

LUMA cervical imaging system.

James E Kendrick1, Warner K Huh, Ronald D Alvarez

  • 1University of Alabama at Birmingham, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Birmingham, AL 35249-7333, USA. tommy.kendrick@obgyn.uab.edu

Expert Review of Medical Devices
|March 16, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Physician Perspectives on the Transition to Primary Human Papillomavirus Testing for Cervical Cancer Screening.

Journal of lower genital tract disease·2026
Same author

Potential of IMNN-001 in epithelial ovarian cancer: assessment of clinical findings.

Expert opinion on investigational drugs·2026
Same author

Nonavalent HPV vaccine to prevent recurrent anal or vulvar high-grade squamous intraepithelial lesions (VIVA trial): A randomized, double-blind, placebo-controlled trial.

International journal of cancer·2026
Same author

Impact of carboplatin desensitization therapy on progression-free survival in gynecologic cancers.

Gynecologic oncology reports·2026
Same author

Feasibility of a mobile health platform for patient education and remote symptom monitoring in patients with advanced ovarian cancer undergoing primary chemotherapy.

Gynecologic oncology·2026
Same author

A Call to Action From the American Gynecological & Obstetrical Society.

Obstetrics and gynecology·2025
Same journal

Review of regulatory requirements for benefit - risk assessment for medical devices: uncovering existing methodologies.

Expert review of medical devices·2026
Same journal

Two sides to every wrist: trans-ulnar access for cardiac interventions.

Expert review of medical devices·2026
Same journal

Comparative review of coronary CT angiography versus conventional catheter angiography: diagnostic value, clinical outcomes, and underlying technical principles.

Expert review of medical devices·2026
Same journal

Assessing the MYNX CONTROL arterial vascular closure device after catheterization procedures that enter the body through the femoral arteries.

Expert review of medical devices·2026
Same journal

Efficacy of two anatomically preformed supraglottic devices, the BlockBuster Laryngeal mask airway and the Ambu AuraGain, for ventilation in anesthetised paralyzed pediatric patients: a randomized trial.

Expert review of medical devices·2026
Same journal

Prismatic treatment combined with binocular visual training for intermittent exotropia: impact on visual function and quality of life.

Expert review of medical devices·2026
See all related articles

The LUMA cervical imaging system improves high-grade cervical intraepithelial neoplasia (CIN) detection during colposcopy. This adjunct increases true positive biopsy rates by 25% for abnormal Pap smears, aiding early cervical cancer detection.

Area of Science:

  • Gynecology
  • Oncology
  • Medical Imaging

Background:

  • Colposcopically directed biopsy is the standard for detecting cervical intraepithelial neoplasia (CIN) and cancer after abnormal Pap smears.
  • Cervical cancer remains a significant health concern globally.

Purpose of the Study:

  • To evaluate the LUMA cervical imaging system as an adjunct to colposcopy for detecting high-grade CIN.
  • To assess the impact of LUMA on the diagnostic accuracy of colposcopy.

Main Methods:

  • Two prospective, randomized controlled trials were conducted.
  • The LUMA system was added to standard colposcopy examinations.
  • Biopsy results were compared between colposcopy alone and colposcopy with LUMA.

Main Results:

Related Experiment Videos

  • The LUMA system increased the true positive biopsy rate for high-grade CIN by at least 25% compared to colposcopy alone.
  • The false-positive rate increased by only 4% with the addition of LUMA.
  • The device showed significant improvement in detecting high-grade CIN in patients with atypical squamous cell or low-grade squamous intraepithelial lesions.

Conclusions:

  • The LUMA cervical imaging system enhances colposcopic examination sensitivity for abnormal cervical cytology.
  • This technology offers a promising tool to further reduce the incidence of cervical cancer.
  • The US FDA approved LUMA in March 2006 for use in improving cervical cancer screening.